BluGlass (ASX:BLG): Interview with CEO Jim Haden

On 29 October 2024, BluGlass CEO Jim Haden talked us through the CLAWS hub, part of the US CHIPS Act,

BluGlass (ASX:BLG): Building a bright future

On 25 July 2023 we spoke with BluGlass CEO Jim Haden and NED Jean-Michel Pelaprat, both laser industry veterans, about

First purchase orders for BluGlass (ASX:BLG): Interview with Jim Haden

On 27 February 2023, we caught up with BluGlass’ (ASX:BLG) President and CEO, Jim Haden, to talk about BLG’s first

Atomo Diagnostics (ASX: AT1) is rapidly building out its diagnostics pipeline

14 May 2025: We spoke with John Kelly, CEO of Atomo Diagnostics (ASX: AT1) about the company's progress with its

Atomo Diagnostics (ASX:AT1): Commercialisation is going into higher gear

On 27 August 2025 we spoke to John Kelly, CEO of Atomo Diagnostics (ASX:AT1), about progress the company is making

BrainChip spoke at the Pitt Street Research Semiconductor Conference 2025

Sean Hehir, CEO of BrainChip, spoke at the Pitt Street Research Semiconductor Conference 2025 held in Sydney on 7 May

BrainChip’s ambitious technology roadmap unlocks many GenAI applications

In a recent interview with BrainChip (ASX:BRN) CEO Sean Hehir, we talked about the company's technology roadmap and how Akida

BrainChip (ASX:BRN): Post AGM interview with CEO Sean Hehir

BrainChip (ASX:BRN): Post AGM interview with CEO Sean Hehir (21 May 2024)

The Calmer Co. (ASX:CCO) almost doubled its revenues in FY25: Interview with CEO Zane Yoshida

On 2 July 2025 we spoke to Zane Yoshida, CEO of the Calmer Co. (ASX: CCO), about the company's progress

Cynata Therapeutics (ASX:CYP) is making steady progress: Interview with Dr. Kilian Kelly

On 13 October 2025 we spoke to Dr Kilian Kelly, CEO of Cynata Therapeutics (ASX:CYP), about the three clinical studies

Dimerix (ASX:DXB) shows encouraging Phase 3 interim results! Interview with CEO Dr. Nina Webster

22 March 2024: We spoke with Dr. Nina Webster, CEO of Dimerix (ASX: DXB), about the company's encouraging interim results

Adisyn : (ASX:AI1) plans to break down the hard, brick wall the semiconductor sector is running into

On 10 April 2025 we spoke with Adisyn's (ASX:AI1) CEO Arye Kohavi and Director Kevin Crofton about the semiconductor interconnect

Dimerix (ASX:DXB) Phase 2 interim data reading should be out soon!

22 February 2024: We spoke with Dr Nina Webster, CEO of Dimerix (ASX: DXB), about the excellent economics behind DMX-200

Dimerix’ (ASX:DXB) interim analysis imminent. Interview with CEO Dr. Nina Webster.

1 February 2024: We spoke with Dr. Nina Webster, CEO of Dimerix (ASX: DXB) about the important Phase 3 study
Register for the Conference